CCMG
IDXX icon

Clark Capital Management Group’s Idexx Laboratories IDXX Stock Holding History

Clark Capital Management Group’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-405
Closed -$228K – 567
2026
Q1 		$228K Buy
405
+34
+9% +$21.8K ﹤0.01% 492
2025
Q4 		$251K Buy
+371
New +$253K ﹤0.01% 452

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Clark Capital Management Group's IDXX Position: Q2 2026 in Review

Clark Capital Management Group sold out of Idexx Laboratories (IDXX) in Q2 2026, closing a stake of 405 shares — an estimated $228K sold.

Clark Capital Management Group first reported a position in IDXX in Q4 2025 and held it in 2 quarters. The position peaked at $251K in Q4 2025. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Clark Capital Management Group reported no remaining Idexx Laboratories position as of Q2 2026 after selling out during the quarter.
  • Clark Capital Management Group sold 405 Idexx Laboratories shares in Q2 2026, an estimated $228K.
  • Clark Capital Management Group first reported a position in Idexx Laboratories in Q4 2025 and held it in 2 quarters.
  • Clark Capital Management Group's Idexx Laboratories position peaked at $251K in Q4 2025.
  • 1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Clark Capital Management Group's 13F filing for Q2 2026, filed 11 Aug 2026.